Skip to main content
Caplight Logo









Reach Orthopaedics

Reach Orthopaedics

Private
HalifaxHealthcare & Life Scienceshttps://reachortho.ca

Last Round

Early Funding

May 23, 2024

Total Funding Raised

$30,000

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Reach Orthopaedics operates in Healthcare & Life Sciences and is based in Halifax. Its latest recorded funding round was a Grant round in April 2020.

Reach Orthopaedics is a medical device company that develops innovative shoulder implants for the treatment of massive, irreparable rotator cuff tears.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Reach Orthopaedics Comparables

Compare Reach Orthopaedics with similar companies based on industry and business-model similarity.

Reach Orthopaedics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Capitan Orthopedics, Inc.
91%
Stryker Corporation
79%
TendonPlus Medical
79%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Reach Orthopaedics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingMay 23, 2024
GrantApr 6, 2020
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors increased 181% MoM.

  • Jul 26, 2026

    Monthly visitors increased 1276% MoM, from 46 to 633.

Book a demo to see all signals

For institutional investors. Book with your work email.

Reach Orthopaedics Filings

Explore SEC and related filing metadata, where available.

Reach Orthopaedics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Reach Orthopaedics's valuation, stock price, and market status.

Is Reach Orthopaedics a public or private company?

Reach Orthopaedics is a private company.

What is the current stock price of Reach Orthopaedics?

Reach Orthopaedics is a private company, so its shares have no public market price. Caplight tracks Reach Orthopaedics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Reach Orthopaedics worth (valuation)?

Valuation information for Reach Orthopaedics is not publicly available.

Can I buy Reach Orthopaedics stock?

Reach Orthopaedics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Reach Orthopaedics's last funding round?

Reach Orthopaedics's most recent funding round was Early Funding on May 23, 2024.

Who are the main investors in Reach Orthopaedics?

Investor information for Reach Orthopaedics is not publicly disclosed.

Will Reach Orthopaedics IPO soon?

No public IPO plans have been announced for Reach Orthopaedics.

How can I track Reach Orthopaedics secondary market activity?

Caplight tracks bids, offers, and trades in Reach Orthopaedics's shares on secondary markets.

Firmographic Details

HeadquartersHalifax
Employee Range3
Year Founded2020
Last FundingMay 23, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?